Edition:
United States

Smith & Nephew PLC (SN.L)

SN.L on London Stock Exchange

1,318.00GBp
21 Sep 2017
Change (% chg)

-4.00 (-0.30%)
Prev Close
1,322.00
Open
1,320.00
Day's High
1,324.00
Day's Low
1,318.00
Volume
75,576
Avg. Vol
3,036,958
52-wk High
1,412.00
52-wk Low
1,064.91

Select another date:

Tue, Sep 5 2017

BRIEF-Smith & Nephew partners with Imperial College to develop surgical techniques in sports medicine

* SMITH & NEPHEW AND IMPERIAL COLLEGE PARTNER TO DEVELOP ENHANCED SURGICAL TECHNIQUES IN SPORTS MEDICINE Source text for Eikon: Further company coverage:

Smith & Nephew buoyed by double-digit emerging markets growth

LONDON, July 27 Artificial hip and knee maker Smith & Nephew reported a 3 percent rise in underlying revenue growth in the second quarter, in line with its 3-4 percent forecast for the year, helped by 13 percent growth in emerging markets.

BRIEF-Smith & Nephew posts H1 operating profit of $414 mln

* H1 REVENUE 2.336 BILLION USD VERSUS 2.328 BILLION USD YEAR AGO

BRIEF-Smith & Nephew appoints Angie Risley as chairman elect of remuneration committee

* Appointment of Angie Risley as non-executive director and chairman elect of remuneration committee Source text for Eikon: Further company coverage:

RPT-UPDATE 1-Emerging markets growth puts Smith & Nephew on track for year

LONDON, May 5 Shares in Smith & Nephew rose to a nine-month high on Friday after the artificial hip and knee maker said a strong first quarter, led by growth in emerging markets, put it on track to meet it targets for the year.

UPDATE 1-Emerging markets growth puts Smith & Nephew on track for year

* Shares rise to nine-month highs (Adds CEO comments, analyst reaction, shares)

Smith & Nephew says M&A 'not at top of agenda' at the moment

LONDON The chief executive of Smith & Nephew said on Friday that M&A was not at the top of his agenda, as the focus was on driving growth at the artificial knee and hip maker.

Smith & Nephew says M&A 'not at top of agenda' at the moment

LONDON, May 5 The chief executive of Smith & Nephew said on Friday that M&A was not at the top of his agenda, as the focus was on driving growth at the artificial knee and hip maker.

Smith & Nephew Q1 revenue rises 3 pct on underlying basis

LONDON, May 5 Smith & Nephew, Europe's biggest artificial hip and knee maker, reported a 3 percent rise in underlying revenue in its first quarter, helped by a return to double-digit growth in emerging markets and a solid performance in knee implants.

Select another date: